Pay in 4 interest-free payments of $6.84 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Meta-analyses conclude that GLP-1 RAs improve metabolic and hormonal parameters in PCOS, though the direct contribution to live birth rates remains uncertain
Product Highlights 1
It is possible to inject subcutaneously into the fatty tissue of the abdomen, thigh, or upper arm
Clinical Implications and Future Outlook: Promising Therapeutic Option: Tirzepatide (and related incretin mimetics like Semaglutide, which also has positive NASH data) are emerging as potentially groundbreaking treatments for NASH, a disease with high prevalence and previously very limited effective pharmacological options
US$ 22.15
US$ 23.01
US$ 27.20
US$ 24.55
US$ 27.88
US$ 25.12
US$ 22.10
US$ 20.70
US$ 21.79
US$ 27.95
US$ 25.87
